CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
4.970
+0.220 (4.63%)
At close: Oct 23, 2026, 4:00 PM EDT
4.542
-0.428 (-8.61%)
After-hours: Oct 23, 2026, 6:04 PM EDT
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $7.26 million as of October 23, 2026. It is the 43,119th most valuable company in the world and the 5,765th biggest in the United States. Its market cap has increased by 47.23% in one year.
Market Cap
7.26M
Enterprise Value
-12.72M
1-Year Change
47.23%
Global Rank
Country Rank
#5,765 United States
Category
ChartMarket Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $7.26M, a decrease of -89.61%. That is a compound annual growth rate of -27.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 7.26M | 123.04% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 8.12M |
| Vistagen Therapeutics | 7.97M |
| Soligenix | 7.94M |
| Chemomab Therapeutics | 7.46M |
| CollPlant Biotechnologies | 6.94M |
| Imunon | 6.93M |
| Exicure | 6.87M |
| Skye Bioscience | 6.82M |